Company intelligence / Profile preview

HALEO

Montreal, Quebec, Canadahaleoclinic.com ↗

Ownership: Private
Development stage: Commercial

Overview

HALEO provides virtual cognitive-behavioral therapy-based programs for insomnia and other sleep disorders. Clinical outcomes have been presented at major conferences such as SLEEP 2019, demonstrating efficacy in improving sleep quality through digital delivery of CBT-I. The company serves both individuals and corporate clients.

Therapeutic areas: PsychiatryNeurology
Modalities: Non-pharmacological therapyDigital therapeutic (Cognitive-Behavioural Therapy for Insomnia / CBT-I)
Industry: Digital Health Medical Devices

Partnerships

Corporate wellness partnerships with large employers/organizations; specific partners not named but includes major Canadian financial institutions as clients since at least 2017

Beyond the preview

Go deeper on HALEO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HALEO.

Explore the full profile